Autoimmune lymphoproliferative syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 37: Line 37:


==[[Autoimmune lymphoproliferative syndrome risk factors|Risk Factors]]==
==[[Autoimmune lymphoproliferative syndrome risk factors|Risk Factors]]==
==[[Autoimmune lymphoproliferative syndrome screening|Screening]]==


==[[Autoimmune lymphoproliferative syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==[[Autoimmune lymphoproliferative syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
Line 45: Line 47:


==Treatment==
==Treatment==
[[Autoimmune lymphoproliferative syndrome medical therapy|Medical Therapy]] | [[Autoimmune lymphoproliferative syndrome surgery |Surgery]] | [[Autoimmune lymphoproliferative syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Autoimmune lymphoproliferative syndrome future or investigational therapies|Future or Investigational Therapies]]
[[Autoimmune lymphoproliferative syndrome medical therapy|Medical Therapy]] | [[Autoimmune lymphoproliferative syndrome surgery |Surgery]] | [[Autoimmune lymphoproliferative syndrome primary prevention|Primary Prevention]] | [[Autoimmune lymphoproliferative syndrome secondary prevention|Secondary Prevention]] | [[Autoimmune lymphoproliferative syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Autoimmune lymphoproliferative syndrome future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==

Revision as of 17:21, 20 June 2016

Autoimmune lymphoproliferative syndrome
OMIM 601859 603909
DiseasesDB 33425 Template:DiseasesDB2

Autoimmune lymphoproliferative syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune lymphoproliferative syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune lymphoproliferative syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune lymphoproliferative syndrome

CDC on Autoimmune lymphoproliferative syndrome

Autoimmune lymphoproliferative syndrome in the news

Blogs on Autoimmune lymphoproliferative syndrome

Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome

Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome

Editor-In-Chief: David Teachey, MD [1]

Synonyms and keywords: Canale-Smith syndrome; ALPS

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune lymphoproliferative syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:WH Template:WS